n-valyltryptophan has been researched along with tryptophan in 1 studies
| Studies (n-valyltryptophan) | Trials (n-valyltryptophan) | Recent Studies (post-2010) (n-valyltryptophan) | Studies (tryptophan) | Trials (tryptophan) | Recent Studies (post-2010) (tryptophan) |
|---|---|---|---|---|---|
| 13 | 0 | 6 | 32,762 | 936 | 7,183 |
| Protein | Taxonomy | n-valyltryptophan (IC50) | tryptophan (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 2.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henle, T; Kaiser, S; Lunow, D; Pohl, C; Rückriemen, J | 1 |
1 other study(ies) available for n-valyltryptophan and tryptophan
| Article | Year |
|---|---|
Tryptophan-containing dipeptides are C-domain selective inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Catalytic Domain; Dipeptides; Humans; Hypertension; Oligopeptides; Peptidyl-Dipeptidase A; Protein Hydrolysates; Structure-Activity Relationship; Tryptophan | 2015 |